Media coverage about Avivagen (NYSE:VIV) has been trending somewhat positive this week, Accern Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Avivagen earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.9321176617503 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
VIV has been the subject of a number of recent research reports. Royal Bank of Canada set a $15.00 target price on shares of Avivagen and gave the stock a “hold” rating in a report on Friday, July 28th. BidaskClub upgraded shares of Avivagen from a “buy” rating to a “strong-buy” rating in a report on Friday, August 4th. Zacks Investment Research downgraded shares of Avivagen from a “hold” rating to a “strong sell” rating in a report on Monday, August 14th. Morgan Stanley reiterated an “equal weight” rating and issued a $15.00 target price on shares of Avivagen in a report on Monday, August 14th. Finally, Barclays PLC upped their price objective on shares of Avivagen from $16.00 to $17.00 and gave the company an “overweight” rating in a report on Monday, October 16th. Three investment analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of C$16.03.
Avivagen (NYSE:VIV) opened at C$14.93 on Friday. Avivagen has a fifty-two week low of C$11.95 and a fifty-two week high of C$16.85.
ILLEGAL ACTIVITY WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Avivagen (VIV) Share Price” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2017/11/12/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-avivagen-viv-share-price.html.
Telefonica Brasil SA is a mobile telecommunications company in Brazil offering postpaid mobile services. The Company also operates as a fixed telecommunications company in the state of Sao Paulo. The Company markets its mobile services under its Vivo brand. It offers its clients a portfolio of products, including mobile and fixed voice, mobile data, fixed broadband, ultra-fast broadband, Pay television, information technology and digital services.
Receive News & Ratings for Avivagen Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avivagen Inc and related companies with MarketBeat.com's FREE daily email newsletter.